LA
ASND icon

LVW Advisors’s Ascendis Pharma A/S ASND Stock Holding History

LVW Advisors’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$253K Sell
946
-79
-8% -$18.5K 0.02% 386
2026
Q1 		$234K Sell
1,025
-140
-12% -$31.4K 0.02% 381
2025
Q4 		$248K Buy
1,165
+8
+0.7% +$1.65K 0.03% 308
2025
Q3 		$230K Sell
1,157
-11
-0.9% -$2.05K 0.02% 320
2025
Q2 		$202K Buy
+1,168
New +$190K 0.02% 321

Other funds holding ASND

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return
SAM
Synergy Asset Management Vancouver, Washington $1.06B AUM 36.26% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
HJIM
Henry James International Management New York $334M AUM 49.44% 1-Year Est. Return

LVW Advisors's ASND Position: Q2 2026 in Review

LVW Advisors reduced its Ascendis Pharma A/S (ASND) stake by 7.7% in Q2 2026, selling an estimated $18.5K and leaving 946 shares worth $253K. The position accounts for 0.02% of the portfolio, ranked #386.

LVW Advisors first reported a position in ASND in Q2 2025 and has held it in 5 quarters since. 59 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

  • LVW Advisors held 946 shares of Ascendis Pharma A/S worth $253K as of Q2 2026.
  • LVW Advisors sold 79 Ascendis Pharma A/S shares in Q2 2026, an estimated $18.5K.
  • Ascendis Pharma A/S made up 0.02% of LVW Advisors's portfolio in Q2 2026, its #386 holding.
  • LVW Advisors first reported a position in Ascendis Pharma A/S in Q2 2025 and has held it in 5 quarters since.
  • 59 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on LVW Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.